These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 24572583)

  • 61. Sex differences in outcome and recovery for schizophrenia and other psychotic and nonpsychotic disorders.
    Grossman LS; Harrow M; Rosen C; Faull R
    Psychiatr Serv; 2006 Jun; 57(6):844-50. PubMed ID: 16754762
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder.
    Sevy S; Robinson DG; Holloway S; Alvir JM; Woerner MG; Bilder R; Goldman R; Lieberman J; Kane J
    Acta Psychiatr Scand; 2001 Nov; 104(5):367-74. PubMed ID: 11722318
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Remission in schizophrenia: results from a 1-year follow-up observational study.
    Ciudad A; Alvarez E; Bobes J; San L; Polavieja P; Gilaberte I
    Schizophr Res; 2009 Mar; 108(1-3):214-22. PubMed ID: 19168329
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical recovery in first-episode psychosis.
    Wunderink L; Sytema S; Nienhuis FJ; Wiersma D
    Schizophr Bull; 2009 Mar; 35(2):362-9. PubMed ID: 18990715
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Psychosocial functioning in relation to symptomatic remission: A longitudinal study of first episode schizophrenia.
    Jaracz K; Górna K; Kiejda J; Grabowska-Fudala B; Jaracz J; Suwalska A; Rybakowski JK
    Eur Psychiatry; 2015 Nov; 30(8):907-13. PubMed ID: 26647865
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous findings.
    Keefe RS; Frescka E; Apter SH; Davidson M; Macaluso JM; Hirschowitz J; Davis KL
    Am J Psychiatry; 1996 Jun; 153(6):806-11. PubMed ID: 8633694
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: assessing courses, types and time stability of diagnostic classification.
    Möller HJ; Jäger M; Riedel M; Obermeier M; Strauss A; Bottlender R
    Eur Psychiatry; 2011 May; 26(4):231-43. PubMed ID: 20621452
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Correlates of frequent gambling and gambling-related chasing behaviors in individuals with schizophrenia-spectrum disorders.
    Yakovenko I; Fortgang R; Prentice J; Hoff RA; Potenza MN
    J Behav Addict; 2018 Jun; 7(2):375-383. PubMed ID: 29788756
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effects of switching from oral to LAI antipsychotic treatment on subjective experience of schizophrenic and schizoaffective patients: Preliminary results.
    Pietrini F; Spadafora M; Talamba GA; Godini L; Lelli L; Arcabasso S; Manetti M; Ballerini A
    Int J Psychiatry Clin Pract; 2015 Jun; 19(2):106-13. PubMed ID: 25410156
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [One-year follow-up and mobility assessment of schizophrenic patients in the Liege psychiatric care network].
    Sarto D; Desseilles M; Martin M; Seidel L; Albert A
    Encephale; 2006 Oct; 32(5 Pt 1):722-8. PubMed ID: 17099596
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms.
    Harrow M; Grossman LS; Herbener ES; Davies EW
    Br J Psychiatry; 2000 Nov; 177():421-6. PubMed ID: 11059995
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Recovery from schizophrenia: results from a 1-year follow-up observational study of patients in symptomatic remission.
    Bobes J; Ciudad A; Alvarez E; San L; Polavieja P; Gilaberte I
    Schizophr Res; 2009 Nov; 115(1):58-66. PubMed ID: 19729283
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Symptomatic remission and associated factors in a catchment area based population of older patients with schizophrenia.
    Meesters PD; Comijs HC; de Haan L; Smit JH; Eikelenboom P; Beekman AT; Stek ML
    Schizophr Res; 2011 Mar; 126(1-3):237-44. PubMed ID: 20888190
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diagnostic profile and suicide risk in schizophrenia spectrum disorder.
    Reutfors J; Bahmanyar S; Jönsson EG; Ekbom A; Nordström P; Brandt L; Ösby U
    Schizophr Res; 2010 Nov; 123(2-3):251-6. PubMed ID: 20692815
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones.
    Iasevoli F; Giordano S; Balletta R; Latte G; Formato MV; Prinzivalli E; De Berardis D; Tomasetti C; de Bartolomeis A
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Feb; 65():34-48. PubMed ID: 26320028
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The relative influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorder.
    Smith TE; Hull JW; Goodman M; Hedayat-Harris A; Willson DF; Israel LM; Munich RL
    J Nerv Ment Dis; 1999 Feb; 187(2):102-8. PubMed ID: 10067950
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Suicidality in middle aged and older patients with schizophrenia and depressive symptoms: relationship to functioning and Quality of Life.
    Kasckow J; Montross L; Golshan S; Mohamed S; Patterson T; Sollanzano E; Zisook S
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1223-8. PubMed ID: 17506025
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders.
    Schennach-Wolff R; Jäger M; Seemüller F; Obermeier M; Messer T; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Huff W; Heuser I; Maier W; Lemke MR; Rüther E; Buchkremer G; Gastpar M; Möller HJ; Riedel M
    Schizophr Res; 2009 Sep; 113(2-3):210-7. PubMed ID: 19560901
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Diagnostic specificity of poor premorbid adjustment: comparison of schizophrenia, schizoaffective disorder, and mood disorder with psychotic features.
    Tarbox SI; Brown LH; Haas GL
    Schizophr Res; 2012 Oct; 141(1):91-7. PubMed ID: 22858353
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset.
    Fond G; Boyer L; Favez M; Brunel L; Aouizerate B; Berna F; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq ; Faget C; Gabayet F; Laouamri H; Lancon C; Le Strat Y; Misdrahi D; Rey R; Passerieux C; Schandrin A; Schurhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Pelissolo A;
    Psychopharmacology (Berl); 2016 Feb; 233(4):571-8. PubMed ID: 26630993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.